“Prostate cancer patients with life expectancies of less than 5 or 10 years were being subjected to treatments that can take up to a decade to significantly improve their chances of surviving cancer, ...

New robotic systems, like CMR and Medtronic's Hugo, are entering the market, increasing competition and innovation in robotic surgery. The da Vinci 5 robot offers incremental improvements, such as ...

Veterans fear losing benefits, leading to hesitancy in undergoing germline testing, impacting access to life-saving treatments. Germline testing is vital in precision oncology, identifying mutations ...

The SURE procedure enhances residual kidney stone removal, addressing limitations of traditional ureteroscopy methods. Traditional techniques often leave residual fragments, leading to potential ...

Patients with elevated CTC count at baseline experienced poor complete response rates and worsened PFS and OS.

“It's really a reapplication of the existing technology for BPH that is familiar to many of us already and we use in our clinical practices,” says Arvin K. George, MD. In this video, Arvin K. George, ...

Significant variability exists in genetic/genomic testing practices for mCRPC across different regions, with 50% of patients recommended for HRR mutation testing. Testing recommendations increased ...

PARP Inhibitors in Metastatic Prostate Cancer: Efficacy, Trials, and Combination Therapies ...

PARP Inhibitors in Metastatic Prostate Cancer: Efficacy, Trials, and Combination Therapies ...

PARP Inhibitors in Metastatic Prostate Cancer: Efficacy, Trials, and Combination Therapies ...

PARP inhibitors are gaining importance in prostate cancer treatment, offering alternatives to androgen deprivation therapy. Treatment strategies from breast and pancreatic cancer are being adapted for ...

Streamlining genetic testing involves patient identification, paperwork, partner selection, and result management, with companies offering germline, somatic, or both types of testing. Genetic testing ...